招商中证全指医疗器械ETF发起式联接A(018395)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
-14,452,052.24 |
195,928.16 |
-2,416,496.63 |
-2,314,423.19 |
| 利息合计 |
30,933.68 |
5,547.97 |
7,124.75 |
2,443.01 |
| 其中：存款利息收入 |
30,933.68 |
5,547.97 |
7,124.75 |
2,443.01 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-1,623,012.68 |
-442,849.96 |
-711,289.70 |
-292,247.75 |
| 其中：股票投资收益 |
192,406.65 |
- |
- |
- |
| 基金投资收益 |
-1,856,469.40 |
-447,603.86 |
-721,561.82 |
-297,091.93 |
| 债券投资收益 |
39,989.30 |
4,753.90 |
10,272.12 |
4,844.18 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
1,060.77 |
- |
- |
- |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-12,999,495.37 |
628,340.74 |
-1,781,035.19 |
-2,026,069.77 |
| 其他收入 |
139,522.13 |
4,889.41 |
68,703.51 |
1,451.32 |
| 费用 |
297,203.69 |
30,718.49 |
41,619.84 |
76,043.82 |
| 管理人报酬 |
27,613.02 |
3,914.55 |
5,130.06 |
1,864.19 |
| 基金托管费 |
5,522.59 |
782.93 |
1,026.15 |
372.84 |
| 销售服务费 |
243,925.37 |
25,336.72 |
24,421.73 |
6,904.02 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
139.65 |
- |
241.90 |
5.03 |
| 其中：卖出回购金融资产支出 |
139.65 |
- |
241.90 |
5.03 |
| 其他费用 |
20,000.00 |
684.29 |
10,800.00 |
66,897.74 |
| 利润总额 |
-14,749,255.93 |
165,209.67 |
-2,458,116.47 |
-2,390,467.01 |
微信公众号
证券之星APP
基本资料
